Raven biotechnologies

From WikiCover

Jump to: navigation, search

Raven biotechnologies, inc. is a privately held biotechnology company focused on the development of monoclonal antibody therapeutics for treating cancer. Raven's lead product candidate, RAV12, targets adenocarcinomas and is in clinical development for the treatment of gastrointestinal and other cancers. Raven, which is based in South San Francisco, California, has identified multiple candidate therapeutic MAbs for many cancer indications including lung, colon, pancreatic, prostate, breast, brain, and ovarian cancer.

Website: http://www.ravenbio.com/

Name (required):

Comment:

Retrieved from "http://www.wikicover.com/Raven_biotechnologies"